AngioDynamics Boosts FY21 Outlook - Quick Facts

(RTTNews) - While reporting financial results for the third quarter on Tuesday, medical devices company AngioDynamics, Inc. (ANGO) raised its adjusted earnings and net sales guidance for the full year 2021.

For fiscal 2021, the company now projects adjusted earnings in a range of $0.04 to $0.06 per share on net sales between $285 million and $288 million.

Previously, the company now expected adjusted earnings in a range of flat to $0.05 per share on net sales between $278 million and $284 million.

On average, three analysts polled by Thomson Reuters expect the company to report earnings of $0.01 per share on net sales of $283.49 million for the year. Analysts' estimates typically exclude special items.